FDA Investigator: Tammy L. Chavis
- Tammy L. Chavis first started conducting FDA inspections in 2000, with the last inspection in 2005. Over that time, Tammy L. Chavis has conducted 100 inspections at 72 companies across 76 sites.
Get Tammy Chavis's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 SPI Pharma, Inc., Lewes | 2005
Out-of-stock
Tammy L. Chavis
Human Drug Form 483
FDA 483 Charles River Laboratories Inc, Malvern | 2004
Out-of-stock
Tammy L. Chavis
Human Drug Form 483
FDA 483 AstraZeneca Pharmaceuticals, LP, Newark | 2004
Out-of-stock
Tammy L. Chavis
Human Drug Form 483
Co-Investigators (13)
- Anita R. Michael, FDA Investigator
- Michael A. Taylor, FDA Investigator
- Maria A. Reed, FDA Investigator
- Gerald W. Kopp, FDA Investigator
- Michael D. Omeara, FDA Investigator
- Michele M. Falchek, FDA Investigator
- Donald L. Lech, FDA Investigator
- Vlada Matusovsky, FDA Investigator
- Debra L. Pagano, FDA Investigator
- Luis A. Dasta, FDA Investigator
- Jean Blackstone Hill, FDA Investigator
- David J. Hafner, FDA Investigator
- Margaret M. Sands, FDA Investigator